Physician profile
Ammar Karim
NPI 1356683924
$22,615.59
in general payments reported to CMS, 2019-2025
8 companies · $19K in 2025
The $19K reported for 2025 was more than what 85% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $896 · 2020: $478 · 2021: $290 · 2022: $353 · 2023: $25.18 · 2024: $1,128 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $5,554 · Food and Beverage: $2,150 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,705.00 |
| Travel and Lodging | $5,553.89 |
| Food and Beverage | $2,149.54 |
| Education | $190.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $15,426.23 | 2022-2025 | Avenir, A.L.P.S., Affixus |
| Smith+Nephew, INC. | $4,920.29 | 2019-2025 | Evos, Smart Tsf, Trigen Intertan |
| Stryker Corporation | $1,228.72 | 2019-2025 | Bio4 |
| Medical Device Business Services, INC. | $860.95 | 2025 | Na |
| Depuy Synthes Sales INC. | $77.77 | 2020-2025 | Na |
| Nuvasive Specialized Orthopedics, INC. | $67.65 | 2019 | |
| Allergan, INC. | $19.62 | 2021 | |
| Biocomposites INC | $14.36 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ammar Karim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.